Tue, February 1, 2011
Mon, January 31, 2011
Sun, January 30, 2011
Fri, January 28, 2011
Thu, January 27, 2011
Wed, January 26, 2011
Tue, January 25, 2011
Mon, January 24, 2011
Sun, January 23, 2011
Sat, January 22, 2011
Fri, January 21, 2011
Thu, January 20, 2011
Wed, January 19, 2011
Tue, January 18, 2011
Mon, January 17, 2011
Fri, January 14, 2011
[ Fri, Jan 14th 2011 ]: Market Wire
ICON Acquires Oxford Outcomes
Thu, January 13, 2011
Wed, January 12, 2011
Tue, January 11, 2011
Mon, January 10, 2011
[ Mon, Jan 10th 2011 ]: Market Wire
30 A.M. ET
Sun, January 9, 2011
Fri, January 7, 2011
Thu, January 6, 2011
Wed, January 5, 2011

SurModics to Webcast First Quarter Fiscal Year 2011 Earnings Conference Call January 26


  Copy link into your clipboard //health-fitness.news-articles.net/content/2011/ .. ar-2011-earnings-conference-call-january-26.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

EDEN PRAIRIE, Minn.--([ BUSINESS WIRE ])--SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it will host a live webcast of its first quarter 2011 conference call on Wednesday, January 26, at 4:00 p.m. CT. The Company will issue an earnings news release after the market closes that afternoon.

Gary Maharaj, chief executive officer, and Phil Ankeny, senior vice president and chief financial officer, will recap the first quarter 2011 financial results and accomplishments. To access the webcast, go to the investor relations portion of the Companya™s website at [ www.surmodics.com ] the day of the conference call and click on the webcast icon.

An audio replay will be available beginning at 7:00 p.m. CT on Wednesday, January 26, until 7:00 p.m. CT on Wednesday, February 2 and can be accessed by dialing 800-406-7325 and entering conference call ID passcode 4401538. In addition, the conference call audio will be archived on the Companya™s website following the call.

About SurModics, Inc.

SurModicsa™ vision is to extend and improve the lives of patients through technology innovation. The Company partners with the worlda™s foremost medical device, pharmaceutical and life science companies to develop and commercialize innovative products that result in improved diagnosis and treatment for patients. Core offerings include: drug delivery technologies (coatings, microparticles, nanoparticles, and implants); surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. SurModics is headquartered in Eden Prairie, Minnesota and its SurModics Pharmaceuticals subsidiary is located in Birmingham, Alabama. For more information about the Company, visit [ www.surmodics.com ]. The content of SurModicsa™ website is not part of this release or part of any filings the Company makes with the SEC.


Publication Contributing Sources